BDSAX
Price
$20.17
Change
-$0.24 (-1.18%)
Updated
Oct 7 closing price
Net Assets
4.35B
VSCPX
Price
$353.56
Change
-$3.58 (-1.00%)
Updated
Oct 7 closing price
Net Assets
162.36B
Interact to see
Advertisement

BDSAX vs VSCPX

Header iconBDSAX vs VSCPX Comparison
Open Charts BDSAX vs VSCPXBanner chart's image
BlackRock Advantage Small Cap Core Inv A
Price$20.17
Change-$0.24 (-1.18%)
VolumeN/A
Net Assets4.35B
Vanguard Small Cap Index InstlPlus
Price$353.56
Change-$3.58 (-1.00%)
VolumeN/A
Net Assets162.36B
BDSAX vs VSCPX Comparison Chart in %
View a ticker or compare two or three
VS
BDSAX vs. VSCPX commentary
Oct 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BDSAX is a Buy and VSCPX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSCPX has more cash in the bank: 162B vs. BDSAX (4.35B). VSCPX pays higher dividends than BDSAX: VSCPX (1.36) vs BDSAX (0.51). BDSAX was incepted earlier than VSCPX: BDSAX (13 years) vs VSCPX (15 years). BDSAX (0.93) is less costly to investors than VSCPX (0.03). BDSAX is a more actively managed with annual turnover of: 88.00 vs. VSCPX (13.00). BDSAX has a lower initial minimum investment than VSCPX: BDSAX (1000) vs VSCPX (100000000). BDSAX annual gain was more profitable for investors over the last year : 13.05 vs. VSCPX (10.45). VSCPX return over 5 years is better than : 59.17 vs. BDSAX (38.56).
BDSAXVSCPXBDSAX / VSCPX
Total Expense Ratio0.750.032,500%
Annual Report Gross Expense Ratio0.930.033,100%
Fund Existence13 years15 years-
Gain YTD11.8297.712153%
Front Load5%N/A-
Min. Initial Investment10001000000000%
Min. Initial Investment IRAN/AN/A-
Net Assets4.35B162B3%
Annual Yield % from dividends0.511.3637%
Returns for 1 year13.0510.45125%
Returns for 3 years52.1748.69107%
Returns for 5 years38.5659.1765%
Returns for 10 years92.37134.5469%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BMIDX18.41N/A
N/A
Brown Advisory Mid-Cap Growth Investor
SLANX34.06N/A
N/A
DWS Latin America Equity A
FTDZX160.73N/A
N/A
Franklin Biotechnology Discovery Adv
FGKMX144.05N/A
N/A
Fidelity Advisor Communication ServicesZ
MLACX4.92-0.03
-0.61%
NYLI Winslow Large Cap Growth Class C